Corona Remedies IPO: Day 2 Sees 9x Subscription, NII Portion 27x

• Corona Remedies IPO was oversubscribed 9 times on Day 2 of public bidding.
• Non-Institutional Investors (NII) portion was booked 27 times, while retail investors subscribed 6 times.
• The IPO, an entirely Offer For Sale (OFS) of Rs 655 crore, has a price band of Rs 1,008-1,062 per share.
• Unlisted shares are trading with over 27% Grey Market Premium (GMP) ahead of listing.
• Analysts suggest focusing on fundamentals for steady returns, noting decent presence but lower profits than some competitors.

Why It Matters: Corona Remedies IPO oversubscription shows strong investor interest.